EZETROL 10 MG TABLETS
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
EZETIMIBE 10 MG
Available from:
MERCK SHARP & DOHME ISRAEL LTD
ATC code:
C10AX09
Pharmaceutical form:
TABLETS
Administration route:
PER OS
Manufactured by:
MERCK SHARP & DOHME CORP., USA
Therapeutic group:
EZETIMIBE
Therapeutic indications:
Primary hypercholesterolemia: Ezetrol administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. Homozygous familial hypercholesterolemia (HoFH): Ezetrol administered with a statin are indicated for use in patients with HoFH.Patients may also receive adjunctive treatments (e.g. LDL apheresis).Homozygous sitosterolemia (Phytosterolemia): Ezetrol are indicated for use in patients with homozygous familial sitosterolemia.
Authorization date:
2013-05-01
